Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2026-03-14 @ 4:21 PM
Study NCT ID:
NCT02807233
Status:
COMPLETED
Last Update Posted:
2019-08-05
First Post:
2016-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects
Sponsor:
Ipsen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07
Start Date Type:
None
Primary Completion Date:
2017-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-27
First Submit QC Date:
None
Study First Post Date:
2016-06-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-01
Last Update Post Date:
2019-08-05
Last Update Post Date Type:
ACTUAL